Charles S Cleeland
Biographic Data
| ID | 5542310 |
|---|---|
| NAME | Charles S Cleeland |
| GIVEN NAMES | Charles S |
| FAMILY NAME | Cleeland |
| SIGNATURE | CLEELAND C S |
| AFFILIATIONS | The University of Texas MD Anderson Cancer Center |
| ORCID | 0000-0002-1460-6527 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 10 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1970 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Defining critical symptom parameters for an ePRO-based management pathway during systemic treatment for advanced upper gastrointestinal cancer: A longitudinal study
Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of Cutpoints
OBJECTIVES: Cutpoints are specific numeric values used to create discrete categories for patient-reported outcome (PRO) items or scales. Cutpoints are widely used in both clinical research and practice. This article offers a definition for cutpoints, describes strategies for determining actionable cutpoints, and discusses considerations related to interpreting cutpoints in clinical applications. METHODS: We clarify the definition of cutpoints for…
Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: An observational study
An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D
This study provides evidence of between-country differences in the self-reporting and valuation of health, including pain/discomfort, when using EQ-5D in general population samples. The results suggest a need for caution when comparing or aggregating EQ-5D self-reported data in multi-country studies
Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma
The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy
Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer
The Association between Symptom Burdens and Utility in Chinese Cancer Patients
MMPI Profiles in Exacerbation and Remission of Multiple Sclerosis
Profile analysis of MMPI profiles generated by 30 patients displaying exacerbation (E) or remission (R) of the symptoms of multiple sclerosis is reported. Profiles classified as “abnormal” were significantly more frequent in the E group. Significantly more E patients had elevations on D greater than 70. The ordering of elevations of the clinical scales was similar in both groups
No prominent works on this page.
MMPI Profiles in Exacerbation and Remission of Multiple Sclerosis
Profile analysis of MMPI profiles generated by 30 patients displaying exacerbation (E) or remission (R) of the symptoms of multiple sclerosis is reported. Profiles classified as “abnormal” were significantly more frequent in the E group. Significantly more E patients had elevations on D greater than 70. The ordering of elevations of the clinical scales was similar in both groups
The Association between Symptom Burdens and Utility in Chinese Cancer Patients
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy
Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer
The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome
An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D
This study provides evidence of between-country differences in the self-reporting and valuation of health, including pain/discomfort, when using EQ-5D in general population samples. The results suggest a need for caution when comparing or aggregating EQ-5D self-reported data in multi-country studies
Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma
Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: An observational study
Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of Cutpoints
OBJECTIVES: Cutpoints are specific numeric values used to create discrete categories for patient-reported outcome (PRO) items or scales. Cutpoints are widely used in both clinical research and practice. This article offers a definition for cutpoints, describes strategies for determining actionable cutpoints, and discusses considerations related to interpreting cutpoints in clinical applications. METHODS: We clarify the definition of cutpoints for…
Defining critical symptom parameters for an ePRO-based management pathway during systemic treatment for advanced upper gastrointestinal cancer: A longitudinal study
Medicine (9 works) · Internal Medicine (7 works) · Cancer survivorship and care (6 works) · Physical therapy (5 works) · Psychology (4 works) · Quality of life (healthcare (4 works) · Clinical Psychology (3 works) · Clinical Psychology (3 works) · Head and Neck Cancer Studies (3 works) · Cancer (2 works)